Glucocorticoids potentiate IL-6-induced SP-B expression in H441 cells by enhancing the JAK-STAT signaling pathway

Andreas Ladenburger1, Matthias Seehase, Boris W Kramer

  • 1Children's Hospital, Univ. of Würzburg, Germany.

Insights

Antenatal steroids and IL-6 synergistically boost surfactant protein B (SP-B) gene expression in lung cells, potentially explaining how prenatal treatments reduce respiratory distress syndrome (RDS) severity in preterm infants.

Area of Science:

  • Pulmonary Medicine
  • Neonatology
  • Molecular Biology
  • Cellular Signaling

Background:

  • Respiratory distress syndrome (RDS) is a major cause of morbidity and mortality in preterm infants.
  • Surfactant protein B (SP-B) deficiency is implicated in RDS pathogenesis.
  • Antenatal corticosteroids and chorioamnionitis (inflammation) reduce RDS severity, involving IL-6 and JAK-STAT signaling.

Purpose of the Study:

  • To investigate the synergistic effects of glucocorticoids (betamethasone/dexamethasone) and IL-6 on SP-B gene expression and STAT3 phosphorylation in H441 lung cells.
  • To elucidate the molecular mechanisms underlying the protective effects of antenatal steroids and inflammation in RDS.

Main Methods:

  • H441 lung cells were treated with betamethasone (BTM), dexamethasone (DXM), and/or IL-6.
  • SP-B mRNA levels were quantified using RT-qPCR.
  • STAT3 phosphorylation was assessed via Western blotting.
  • JAK inhibitor was used to block signaling pathways.
  • IL-6 receptor (IL-6R) expression was analyzed at mRNA and protein levels.

Main Results:

  • Both DXM and BTM significantly increased SP-B mRNA levels.
  • IL-6 alone also increased SP-B mRNA, but combined treatment with glucocorticoids and IL-6 resulted in a synergistic, greater increase.
  • Glucocorticoids did not phosphorylate STAT3 but potentiated IL-6-induced STAT3 phosphorylation.
  • This synergism was blocked by a JAK inhibitor, and glucocorticoids upregulated IL-6R expression.

Conclusions:

  • Glucocorticoids and IL-6 exhibit a synergistic effect on SP-B gene expression in lung cells, mediated by the JAK-STAT pathway.
  • Glucocorticoids enhance IL-6 signaling by upregulating the IL-6 receptor, providing a potential mechanism for their protective effects against RDS.
  • These findings offer in vitro insights into how antenatal steroid administration combined with prenatal inflammation can mitigate RDS severity in preterm neonates.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...